OTCQB: IZOZF
CSE: IZO
FSE: 1R3
Home
IzoView
Presentations
Breast CT Clinical Data
Media
Images
Videos
Podcast
News
Team
Team Fact Sheets
Management
Advisors
Investors
Investor Presentation
Why Invest?
Stock Info
Financials
Contact
Menu
Investors
Investor Presentation
Investor Presentation
Investor Presentation
Why Invest?
Stock Info
Financials
IzoView
Presentations
Breast CT Clinical Data
Media
Images
Videos
Podcast
News
Izotropic Launches Podcast Episode #1: Beyond the Mammogram: Rethinking the Future of Breast Imaging
Izotropic’s IzoView Positioned to Capitalize on Key Global Breast Imaging Market Drivers
Izotropic’s IzoView Breast CT Device Stands Distinct vs Existing Breast Imaging Technologies
Izotropic Provides Marketing Update
Izotropic Updates License Agreement Terms with University of California
Izotropic’s U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update
Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender
Izotropic Completes Pre-Submission Meeting with FDA for Breast Cancer Screening Indication
Izotropic to Present at Investor Conference March 13th
FDA Sets Meeting Date with Izotropic
Izotropic Closes Non-Brokered Private Placement
Izotropic Announces Non-Brokered Private Placement- February 2025
Izotropic Announces Timelines and Milestones to IzoView Product Launch
Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast
Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions
Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening
Team
Team Fact Sheets
Management
Advisors
Investors
Investor Presentation
Why Invest?
Stock Info
Financials
Contact
